RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Pomalidomide reduces bleeding and alters expression of angiogenesis-related proteins in patients with hereditary hemorrhagic telangiectasia
Swaidani, S., Kundu, S., Samour, M., Silver, B., Parambil, J., Thomas, S., & McCrae, K. R. (2019). Pomalidomide reduces bleeding and alters expression of angiogenesis-related proteins in patients with hereditary hemorrhagic telangiectasia. Blood, 134(Supplement_1). https://doi.org/10.1182/blood-2019-127344
